Key takeaways:
Gabapentin is a medication that healthcare providers use to treat seizures, nerve pain from shingles, and restless leg syndrome.
Despite previous marketing claims, there’s no evidence that gabapentin is a useful treatment for bipolar disorder.
The best treatment for bipolar disorder is a combination of other medications, including mood stabilizers, anticonvulsants, and antipsychotics.
Gabapentin (Neurontin) is one of the top ten most frequently prescribed medications in the U.S. It’s an anti-epileptic medication that can treat seizures. But it can also treat many other conditions — both on and off-label. And, spoiler alert, the benefits don’t always live up to the hype. The popularity of gabapentin is the result of decades-long, misleading marketing campaigns.
Gabapentin does work well for some conditions. There’s good evidence that gabapentin is helpful for certain types of nerve pain and anxiety.
But what about bipolar disorder? Not so much. The truth is, according to research studies, gabapentin is not an effective treatment for bipolar disorder.
Read on for more information about how gabapentin was marketed for treating bipolar disorder in the past and what the current research says about gabapentin and bipolar disorder.
There’s no evidence that gabapentin works for treating bipolar disorder. This is a misconception fueled by an unethical drug company marketing campaign from the 1990s. The manufacturer of brand-name gabapentin (Neurontin) heavily marketed it for many different off-label uses, including bipolar disorder. At the time, the manufacturer had no good scientific evidence to support these claims — only industry-funded, poor-quality studies.
In 1996, a whistleblower from inside the drug company came forward. He claimed that company employees were trained to aggressively market Neurontin to doctors for off-label uses. Employees were also encouraged to “exaggerate the results of studies that were too small to prove anything, and to hide reports of side effects or trials that showed Neurontin did not work for various conditions.”
This led to a $430 million false claims settlement in 2004, after it was determined that the drug company had inappropriately promoted off-label uses of gabapentin and defrauded the federal government.
Since that time, researchers have continued to investigate gabapentin. But according to literature reviews from 2015, 2021, and again in 2021, there’s no significant evidence that gabapentin is effective for treating bipolar disorder — either on its own or as an add-on medication. In fact, in some studies, gabapentin actually performed worse than placebo.
Here’s what the experts say about gabapentin and bipolar disorder:
American Psychological Association: Gabapentin has been “largely discredited as a mood stabilizer for bipolar disorder.”
Depression and Bipolar Support Alliance: Gabapentin “was used frequently for treatment of bipolar disorder, but controlled studies found it was no more effective than a placebo.”
American Academy of Child and Adolescent Psychiatry: Gabapentin has “not been shown to effectively treat mania or depression associated with bipolar disorder.”
In short, there are much better medications for bipolar disorder than gabapentin — especially since there’s growing evidence that gabapentin has significant risks.
Just like all medications, gabapentin can cause some side effects. For most people, these side effects are mild, and they include:
Fatigue
Dizziness
Tremor
Upset stomach
Constipation or diarrhea
Arm and leg swelling
When taken as directed, mania is not a typical side effect of gabapentin. But keep in mind: People who misuse gabapentin say it can feel stimulating, like cocaine. They report feeling more talkative, having increased energy, and feeling euphoric — symptoms that are similar to mania. You should not take gabapentin unless a healthcare provider specifically recommends it.
The FDA has approved gabapentin (Neurontin) for:
Another version of gabapentin (Horizant) is approved to treat restless leg syndrome and PHN.
There’s also Gralise, an extended-release version of gabapentin, which is only approved for PHN.
Healthcare providers also frequently prescribe it off-label for dozens of conditions — including bipolar disorder, chronic back pain, and anxiety. Most of these indications (like bipolar disorder and chronic back pain) do not have good evidence supporting them. But for some of these off-label uses, it can be helpful. For example, there’s some evidence that gabapentin is helpful for certain types of anxiety and for treating substance use disorders.
As we’ve seen, bipolar disorder is an off-label use for gabapentin. And after decades of research, experts do not recommend gabapentin as a treatment for bipolar disorder.
The treatment for bipolar disorder uses a combination of medications, including mood stabilizers, other anticonvulsants, and antipsychotics. Examples include lithium, seroquel, lamictal, and more.
If you have bipolar disorder and you also have anxiety or a substance use disorder, your healthcare provider might suggest adding on gabapentin.
There are many good medications for bipolar disorder, but gabapentin isn’t one of them. Unless you’re looking for an add-on medication to treat a specific symptom — like anxiety — there are better medications for managing your condition. Talk to your provider about the risks and benefits of gabapentin versus other medications. That way you can understand whether it makes sense to include it in your treatment plan.
American Academy of Child and Adolescent Psychiatry. (2009). Parents’ medication guide for bipolar disorder in children & adolescents.
American Psychological Association. (n.d.). Gabapentin.
Berlin, R., et al. (2015). Gabapentin therapy in psychiatric disorders: A systematic review. The Primary Care Companion for CNS Disorders.
Calabrese, J. (n.d.). Are there any seizure control medications that have no crossover for use in bipolar treatment?. Depression and Bipolar Support Alliance.
Goodman, C., et al. (2019). Gabapentinoids for pain: Potential unintended consequences. American Family Physician.
Fullerton, C., et al. (2016). The rise and fall of gabapentin for bipolar disorder: A case study on off-label pharmaceutical diffusion. Medical Care.
Hong, J., et al. (2021). Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Molecular Psychiatry.
Krautkramer, C. (2006). Neurontin and off-label marketing. AMA Journal of Ethics.
Ng, Q., et al. (2021). A systematic review of the clinical use of gabapentin and pregabalin in bipolar disorder. Pharmaceuticals.
Peckham, A., et al. (2018). Gabapentin for off-label use: Evidence-based or cause for concern?. Substance Abuse.
Petersen, M. (2003). Doctor explains why he blew the whistle. The New York Times.
Post, R., et al. (2022). Bipolar disorder in adults: Choosing maintenance treatment. UpToDate.
Smith, R., et al. (2016). Gabapentin misuse, abuse, and diversion: A systematic review. Addiction.
Walling, A. (2005). Evidence-based guidelines for bipolar disorder therapy. American Family Physician.
Williams, J., et al. (2009). How reviews covered the unfolding scientific story of gabapentin for bipolar disorder. General Hospital Psychiatry.
Yasaei, R. (2021). Gabapentin. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.